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Abstract
Although prominent personality theories postulate orthogonality between traits of
positiveemotionality(PEM)andnegativeemotionality(NEM),empiricalevidence
often demonstrates the opposite indicating a negative relationship. Therefore, it
is not surprising that dopaminergic (DA) gene loci have been related to traits of
positiveandofNEM.Thepresentgeneticassociationstudyinvestigatestheinﬂuence
of two functional DA gene polymorphisms on Sadness as deﬁned by the Affective
Neuroscience Personality Scales (ANPS) in healthy Caucasians (n = 1041). We
observed a signiﬁcant interaction effect between the 10-repeat (10R) allele of the
dopaminetransporter(DAT1)geneandthemethionine(Met)alleleofthecatechol-
O-methyltransferase (COMT) Val158Met polymorphism (F(1,1018) = 11.11; P <
0.001).Carriersofthe9R/9RandtheVal/Valgenotypeshoweddramaticallyreduced
Sadness scores in comparison to the other three genotype conﬁgurations. Both the
9R/9R and the Val/Val genotypes characterized by reduced transporter density and
high dopamine catabolism, respectively, have been separately related to personality
traits of PEM and externalizing behavior in the past. The present ﬁndings indicate
that gene variations of the DA system previously associated with PEM are at the
same time protective against high NEM and can therefore constitute a resilience
factor against depression.
Introduction
Dopaminergic (DA) neurotransmission plays a crucial role
for human personality with implications for affective dis-
orders. With respect to the DA system it has been shown
that the same biological basis is related to variability in per-
sonality and psychopathology(Dunlop and Nemeroff 2007).
Thus, personality traits and also the vulnerability for and the
severityofpsychopathologicaldisorderscanbeinterpretedas
variations of a common underlying dimension. This implies
a natural continuum between high and low levels of a cer-
tain personality trait dimension and only extreme variations
at the end of trait scales result in symptoms of psychiatric
illness (Donnelly 1998). Moreover, DA neurotransmission
is implicated in the regulation of reward and cognitive pro-
cesses(BressanandCrippa2005;YacubianandBuchel2009).
Most relevant for the present study, there is mounting evi-
d e n c et h a tt h eD As y s t e mp l a y sar o l ei nt h ep r o c e s s i n go f
positive emotionality (PEM) as well as of negative emotion-
ality (NEM) (Reuter and Hennig 2005; Montag et al. 2010)
leading to the hypothesis that PEM and NEM constitute a
unidimensionalbipolarconstructandthatthepositionofan
individualonthiscontinuumischaracterizedbytheamount
of DA availability in the central nervous system. In other
words,DAcanbedescribedasthe“YinandYangprincipleof
personality.” In personality psychology, there is still a debate
o nt h eq u e s t i o ni fP E Ma n dN E Ma r eo r t h o g o n a lc o n s t r u c t s
or represent—as hypothesized in the present study—a uni-
dimensional bipolar construct. In this context, it is stressed
that the thought of a continuum model to personality traits
isinparticularobservableintraitslinkedtoapproach(PEM)
andavoidancebehavior(NEM—seesupplementarymaterial
for further explanations). This hypothesis is corroborated by
studies in humans, where dopamine D2 receptor (DRD2)
blockade results in an impaired recognition of emotionally
negative stimuli (Mehta et al. 2005). DA antagonists also
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r educemotivationandmoodandinducestatesofdepr ession
(Bressan et al. 2002; Verhoeff et al. 2003). On the other side
data from human pharmacological imaging studies demon-
strate that an increase of extracellular dopamine in the stria-
tum is correlated with the experience of positive mood states
(Drevetsetal.2001;Laruelleetal.1995).Furthermore,genet-
ically inﬂuenced differences in DA transmission contribute
to individual differences in reward-seeking behavior during
functional magnetic resonance imaging (fMRI) suggesting
that variation in DA availability modulates affective states
(Dreher et al. 2009). In general, the association between DA
activityanddepression(DunlopandNemeroff2007)isbased
on the fact that the neurotransmitter DA is involved in ap-
proach behavior (Schultz 1998) and depression is related to
deﬁcits in the approach system associated with reduces posi-
tive affect (see Shankman and Klein 2003 for a review).
Tosumup,contrarytoempiricalﬁndingsmentionedabove
prominent personality theories postulate orthogonality of
personality dimensions, but growing empirical evidence in-
dicates a negative correlation between traits of positive and
NEM (for an overview see Reuter 2008). Heritability esti-
mates for personality traits as well as for psychopatholo-
gies are rather high indicating that the genetic background
(genotype) of a person accounts substantially for individ-
ual differences in behavior and the predisposition to psychi-
atricdisorders.Geneticassociationstudiesprovideconsider-
able evidence that DA genes are associated with personality
traits and a range of psychiatric phenotypes. For instance,
for the well-studied DA candidate genes coding for catechol-
O-methyltransferase (COMT) and DRD2, a signiﬁcant in-
teraction for the total Behavioral Activation System (BAS)
scale related to PEM and also higher scores on extraversion
and PEM for COMT valine (Val) allele carriers have been
reported (Reuter and Hennig 2005; Reuter et al. 2006). In
line with the “Yin and Yang principle of dopamine” results
for the COMT polymorphism showed an association of the
methionine (Met) allele with personality traits primarily re-
lated to NEM (Enoch et al. 2003; Eley et al. 2003; Rujescu
etal.2003).Despitethisconvergentevidence,theproportion
of variance accounted for by a single polymorphism is rather
low.Complexphenotypesofhighheritabilitysuchasperson-
ality traits are inﬂuenced by the interplay of many different
genes (Reif and Lesch 2003), resulting in a wide variance
of individual behavioral dispositions. In order to investigate
the role of the DA system for personality, we have to keep
in mind that DA genes interact to determine the efﬁcacy of
the DA system by inﬂuencing the expression and distribu-
tion of the gene products within the brain. In particular, DA
activity depends on synthesis rates, catabolism, and receptor
density but also on further enzymes and proteins regulating
DA neurotransmission (see Opmeer et al. for an overview).
Numerous polymorphisms in the corresponding genes can
have major inﬂuence on DA metabolism and neurotrans-
mission. A vast body of evidence from studies in humans
as well as animals illustrates the pivotal role of COMT and
thedopaminetransporter(DAT1)inDAneurotransmission.
Since both polymorphisms are well studied and shown to be
functional,thepresenttheory-basedstudyofCOMT×DAT1
geneinteractiontakesapharmacologicalrelevantinteraction
into account. Both COMT, as a catecholamine catabolizing
enzyme, and the DA transporter, DAT1, work together to
clear extracellular DA from the synaptic cleft. In doing so,
theyregulatesynapticDAconcentrationsinthebrainmainly
incorticalandsubcorticalregions.Acontributionofboththe
COMT and the DAT1 polymorphisms to the activity of the
DA system and an interaction (epistasis effect) of these genes
is quite likely, at least from a pharmacological viewpoint.
Inhumans,theCOMTgenecontainsafunctionalnonsyn-
onymous single nucleotide polymorphism (SNP), a guanine
to adenine transition in codon 158 of the COMT gene lo-
cated at the q11 band of human chromosome 22 (rs#4680).
The substitution of the amino acid Val by Met results in de-
creased thermostability of the protein leading to a three- to
fourfold reduced COMT enzyme activity at physiologically
relevant temperatures. The COMT alleles are codominant
with three genotypes possible: carriers of the Val/Val geno-
type have highest, carriers of the Met/Met genotype have
lowest, and heterozygotes (Val/Met genotype) have interme-
diate levels of COMT enzyme activity (Lachman et al. 1996;
Chen et al. 2004; Weinshilboum et al. 1999). Consistently,
the number of Met alleles is positively related to prefrontal
DA levels (Tunbridge et al. 2006). The involvement of the
COMTVal158Metpolymorphisminemotionalprocessingis
supported by numerous association studies relating the Met
allele or the Met/Met genotype to anxiety disorders (Enoch
et al. 2003; Domschke et al. 2004; McGrath et al. 2004; Woo
et al. 2004; Olsson et al. 2005; Montag et al. 2008), anxiety-
related traits including high neuroticism, and low sensation
seekingandlowextraversion(ReuterandHennig2005;Stein
et al. 2005; Lang et al. 2007) and obsessive-compulsive dis-
order (Pooley et al. 2007). A diminished stress resilience and
emotionalregulationfortheMetallele(Goldmanetal.2005)
is in line with an association with increased pain sensitiv-
ity (Zubieta et al. 2003). In addition, the Met allele is as-
sociated with the onset of mood disorders after exposure
to adverse life events (Mandelli et al. 2007). These ﬁndings
suggest that the COMT Val158Met polymorphism and espe-
ciallytheMet/Metgenotypeleadstoincreasedpredisposition
to emotional disorders, with anxiety and depression as the
most common ones. However, it must be noted that despite
of this high convergent validity that relates the Met allele to
NEM and the Val allele to PEM, there are also some studies
reporting conﬂicting results.
The human dopamine transporter (DAT1/SLC6A3) gene
localizedonchromosome5p15.3containsa40basepair(bp)
variable number of tandem repeats (VNTR) polymorphism
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in its 3 -untranslated region (3 UTR) with repeat numbers
ranging from 3 to 11. The two most frequent alleles in the
population are the nine- and 10-repeat (9R and 10R) alle-
les (Vandenbergh et al. 1992). An increased level of DAT1
expression is most common associated with the 10R allele
than with the 9R allele (Heinz et al. 2000; Fuke et al. 2001;
Mill et al. 2002; VanNess et al. 2005), although some studies
reported the opposite (Jacobsen et al. 2000; Van Dyck et al.
2005)ornodifferencesbetweengenotypesandDAT1expres-
sionrates(Martinezetal.2001;Krauseetal.2006;Costaetal.
2011). The functional DAT1 VNTR polymorphism directly
alters DAT1 density and activity in the brain mainly in the
striatum. Individuals carrying two copies of the 10R allele
havehigherDAT1densityandthereforelessdopamineinthe
synaptic cleft than 9R carriers (Heinz et al. 2000). Hence,
the presynaptic neuronal membrane protein DAT1 plays a
pivotal role in terminating DA neurotransmission, as it me-
diates active reuptake of DA into the presynaptic nerve ter-
minals (Giros and Caron 1993). DAT1 is implicated in DA-
related personality, emotional processing, and pathologies
associatedwithdysregulationofDAtransmissionsuchasde-
pression, attention deﬁcit-hyperactivity disorder (ADHD),
Parkinson’s disease, schizophrenia, cocaine-induced para-
noia,tobaccosmoking,andalcoholdependence(Greenwood
etal.2002;Mehler–Wexetal.2006;Samochowiecetal.2006;
Haeffel et al. 2008; Garcia–Garcia et al. 2010). Garcia-Garcia
et al. (2010) reported a DAT1-dependent enhancement of
novelty processing in a negative emotional context. Individ-
uals with at least one 9R allele (associated with larger striatal
DA levels) showed larger distraction as 10R/10R individu-
als (associated with less striatal DA levels). Further studies
reported a lower risk of smoking addiction for 9R allele car-
riers (Lerman et al. 1999; Sabol et al. 1999). Recently Guo
et al. (2010) showed that the 9R/9R genotype exerts a gen-
eral protective effect against a spectrum of risky behaviors in
comparison to the 10R/9R and 10R/10R genotypes. Lower
scores on neuroticism are associated with carriers of at least
onecopyofthe9RalleleincombinationwiththeMetalleleof
the Brain-derived neurotrophic factor (BDNF) gene (Huen-
nerkopf et al. 2007). In addition, a role of the DAT1 gene in
the development of depression was reported (Haeffel et al.
2008; Brunswick et al. 2003). However, similar to the COMT
Val158Met polymorphism, the DAT1 VNTR polymorphism
have been examined in several psychiatric studies with het-
erogeneousresultsdependentonphenotypeandgroupingof
DAT1 alleles (Opmeer et al.; Huang et al. 2011).
To date, only a few studies have explored the genetic inter-
action between COMT and DAT1. Previous studies reported
an interaction between both genes in cortical regions in rela-
tion to schizophrenia (Prata et al. 2009), on reward process-
ing and cognition (Bertolino et al. 2006; Caldu et al. 2007;
Yacubian et al. 2007; Bertolino et al. 2008; Alexander et al.
2011) reported epistasis between COMT Met and DAT1 10R
resulting in elevated cortisol reactivity and impaired stress
recovery. Moreover, an interaction between both polymor-
phismswasobservedinAlzheimerpatients,inwhichcarriers
of the DAT1 10R without COMT Val allele exhibit signiﬁ-
cantly lower agitation levels (Proitsi et al. 2010).
The aim of the present study was to examine the existence
ofanonadditive/epistaticinteractionbetweentwofunctional
polymorphisms COMT Val158Met and DAT1 3 UTR VNTR
in a large cohort of healthy Caucasian subjects. Especially,
we wanted to explore potential associations between risk al-
leles/genotypes of both genetic polymorphisms for NEM as
measured by the Affective Neuroscience Personality Scales
(ANPS) questionnaire. The ANPS was chosen for this study
because,unlikepersonalityquestionnairesderivedfromalex-
ical approach, this scale has been constructed to reﬂect most
directlyemotionalneuronalcircuitsofthemammalianbrain
(Davis et al. 2003). We hypothesized that the association of
DAT1 with NEM is dependent on genetic variation of the
COMT gene because the Met allele of COMT has been pre-
viously associated with NEM and the Val/Val genotype with
PEM. DA variation should inﬂuence vulnerability to nega-
tive emotions, possibly due to changes in DA availability. We
hypothesizedthatcarriersofthe9R/9RandVal/Valgenotype
conﬁgurationwouldshowlowestscoresonNEM,asassessed
by the ANPS scales Sadness, Anger, and Fear.
Material and Methods
Participants
A total of 1041 healthy Caucasians of German origin ﬁlled
in a paper-and-pencil version of the ANPS. In addition, all
participantsprovidedbuccalswapsforgenotypingofCOMT
rs#4680 and DAT1 rs#28363170 polymorphisms. The sam-
ple consisted of 358 males and 683 females. Mean age was
25.42 years (SD = 7.86, age range: 18–76 years). Partici-
pants were recruited at the University of Bonn, Germany.
The presence of exclusion criteria or former ICD-10 diag-
nosis of psychopathology was assessed by a self-constructed
screening questionnaire. The report of any present or former
psychiatricorneurologicaldisordersledtoanexclusionfrom
thestudy.Thestudyprotocoladherestotheethicalprinciples
of the Declaration of Helsinki of the World Medical Associ-
ation and was approved by the local ethics committee at the
University of Bonn. All participants gave written informed
consent to participate in this study.
Self-report questionnaire
Participants completed the German version of the ANPS
personality questionnaire (Davis et al. 2003; Davis and
Panksepp 2011). This self-report measure of behavioral
dispositionswasusedbecausetheconstructionofthisinven-
torywasbiologicallymotivatedbyatheoryofbasicemotional
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systems that was validated across mammalian species
(Panksepp 1998). Each scale of the ANPS has been built in
analogy to the existence of basic emotional neuronal circuits
of the mammalian brain. The ANPS consists of 110 items,
scaled on a four-point Likert scale ranging from “strongly
disagree” to “strongly agree.” The questionnaire measures
six personality dimensions, three of positive (Play, Seek,
Care) and three of negative (Fear, Anger, Sadness) experi-
ence. Moreover, a scale measuring Spirituality is included in
the questionnaire, due to its potential importance for the
treatment of alcoholics. The Sadness dimension that is rele-
vant to this study refers to feelings of loneliness and distress,
thinking about loved ones and frequent crying.
Genotyping
DNA was extracted from buccal mucosa cell samples. Auto-
matedpuriﬁcationofgenomicDNAwasconductedbymeans
oftheMagNAPureLCsystemusingacommercialextraction
kit (MagNA Pure LC DNA isolation kit; Roche Diagnostics,
Mannheim, Germany).
The VNTR polymorphism of the DAT1/SLC6A3 gene
(rs#28363170)wasampliﬁedfromgenomicDNAusingpoly-
merase chain reaction (PCR) and the primers 5 -TGTGGT
GTAGGGAACGGCCTGAG-3  and 5 -CTTCCTGGAGGTC
ACGGCTCAAGG-3 . In brief, after an initial denaturation
for 3 min at 94◦C, 39 cycles of denaturing at 94◦Cf o r4 5s e c ,
annealingat62◦Cfor30sec,andextensionat72◦Cfor30sec
were followed by a ﬁnal extension at 72◦Cf o r5m i n .P C R
ampliﬁcation was carried out in a ﬁnal volume of 20 μl
consisting of 50 ng genomic DNA, 0.2 mM of each deoxyri-
bonucleotide, 1 pmol of sense and antisense primers, 1 U of
GoTaq-Polymerase (Promega, Mannheim, Germany), and
the enzyme supplier’s buffer. Ampliﬁcation products were
analyzed by 2% agarose gel electrophoresis. The sizes of the
8, 9, 10, and 11 repeats were 360, 400, 440, and 480 bp,
respectively.
Genotyping of COMT Val158Met SNPs (rs#4680) was
performed by real time PCR (RT-PCR) using ﬂuorescence
melting curve detection analysis by means of the Light Cy-
cler System (Roche Diagnostics, Mannheim, Germany). De-
tails of the PCR protocol are described elsewhere (Reuter
et al. 2006). The primers and hybridization probes used
(TIB MOLBIOL, Berlin, Germany) were as follows: for-
ward primer: 5 -GGGCCTACTGTGGCTACTCA-3 ;r e v e r s e
primer: 5 -GGCCCTTTTTCCAGGTCTG-3 ;s e n s o rh y -
bridization probe: 5 -ATTTCGCTGGCATGAAGGACAAG-
ﬂuorescein-3 ; anchor hybridization probe: 5 -LCRed640-
TGTGCATGCCTGACCCGTTGTCA-phosphate-3 .
Statistical analysis
We investigated the inﬂuence of COMT and DAT1 on ANPS
personality dimensions by means of analysis of variance
(ANOVA). On the genotype levels, the independent factors
hadthreelevelseach(COMT:Val/Val,Val/Met,andMet/Met;
DAT1: 9R/9R, 9R/10R, and 10R/10R). For statistical analy-
ses focusing on gene × gene interactions, COMT and DAT1
genotypes were dichotomized to enhance statistical power.
IndividualswiththeCOMTMet/MetandVal/Metgenotypes
were combined (Met+ andMet− for Val/Val) basedon ﬁnd-
ingsthattheVal/ValgenotypeisassociatedwithPEM(Reuter
and Hennig 2005) and the Met allele with NEM (Enoch et
al. 2003). The DAT1 10R/10R and 10R/9R genotypes were
dichotomized for the presence (10R+) or absence (10R−)
of the DAT1 10R allele as DAT1 expression is higher in the
presence of the 10R allele (Fuke et al. 2001; Mill et al. 2002).
Age was negatively correlated with Sadness (r =− .113, P <
0.001) and positively with Seek (r = .088, P = 0.005) and
was therefore included as covariate into all ANOVA models.
In order to test and to control for possible gender effects, an
ANOVA with gender as ﬁxed factor and the ANPS subscales
as independent variableswas conducted. Since no signiﬁcant
association between gender and ANPS scores was observed,
gender was not included in further analyses. All statistical
tests were conducted at a P < 0.05 threshold and signiﬁcant
results were corrected for multiple testing according to the
Bonferroni correction. All analyses were carried out using
SPSS 18.0.0 (SPSS Inc., Chicago, IL).
Results
Sample characteristics
Genotype frequencies of the COMT and the DAT1 polymor-
phisms were as follows: For COMT Val158Met Val/Val: n =
251, Val/Met: n = 498, Met/Met: n = 292 and for DAT1
VNTR 9/9: n = 72, 9/10: n = 381, 10/10: n = 570, 10/11: n
= 13, 9/11: n = 4, and 8/10: n = 1. The genotype distribu-
tionsforbothgenelociwereinHardy–Weinbergequilibrium
(COMT: χ2 = 1.81, df = 1, ns; DAT1: χ2 = 0.58, df = 1,
ns) and did not differ between gender groups (COMT: χ2
= 3.05, df = 2, ns; DAT1: χ2 = 0.10, df = 2, ns). In our
analyses, we focused solely on individuals with DAT1 geno-
types homozygous for 10R and 9R and heterozygous 9R/10R
(N = 1023). The individuals with rare genotypes (1.7%)
were excluded from the analyses. Allele frequencies were as
follows: COMT: 48% Val and 52% Met alleles, DAT1: 25%
9R and 73% 10R alleles. There were no differences in allelic
distributions between both gender groups (χ2 = 3.71, df =
1, ns). The resulting sample distribution over the four allelic
conﬁgurations of interest is depicted in Table 1.
COMT, DAT1, and the personality dimension
of Sadness
There was no main effect for the DAT1 VNTR polymor-
phism on any of the ANPS subscales. The COMT Met allele
showed a signiﬁcant association with the subscales Sadness
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Table 1. Number of participants in the allelic conﬁgurations of interest
(N = 1023).
DAT1 COMT n
10R− Met− 19
Met+ 53
10R+ Met− 229
Met+ 722
Figure 1. Means and Standard errors of means (SEM) of the ANCOVA
for the Sadness dimension of the ANPS dependent on the signiﬁcant
interaction of COMT Met and DAT1 10R. Age was inserted as covariate
into the ANOVA.
(F(1,1018) = 7.55, P = 0.006) and Anger (F(1,1019) = 4.19, P =
0.04). Moreover, we found a signiﬁcant interaction between
COMT Met and DAT1 10R on Sadness (F(1,1018) = 11.11,
P < 0.001). Lowest Sadness scores were observed in carriers
of the genotype conﬁguration 10R- and Met- (9R/9R and
Val/Val). Results are depicted in Figure 1. Post hoc tests us-
ing the Bonferroni method revealed that COMT Met-/DAT1
10R- carriershad signiﬁcantly lower Sadness scores than car-
riers of the other three conﬁgurations: COMT Met-/DAT1
10R+ (P = 0.016), COMT Met+/DAT1 10R- (P = 0.007),
and COMT Met+/DAT1 10R+ (P = 0.038). No other com-
parisonsreachedsigniﬁcance.Furthermore,noneoftheother
interactionsbetweenthetwopolymorphismsweresigniﬁcant
(all P-values > 0.05; Table 2). Only Fear, a construct highly
correlated with Sadness (r = .685, P < 0.001; correlation
matrix in supplementary material) that also reﬂects NEM,
showed a tendency for signiﬁcance (F(1,1019) = 2.88, P =
0.06). After Bonferroni correction for multiple testing, only
the main effect of the COMT Met allele and the interaction
of COMT Met with DAT1 10R on the Sadness dimension re-
mained signiﬁcant, whereas the COMT Met effect on Anger
could not hold after adjusting the statistical threshold.
Discussion
Inalarge,healthysample,weassessedtheeffectsoffunctional
polymorphisms in the COMT and the DAT1 gene, which
regulate synaptic levels of DA in the brain and modulate
central DA function. We hypothesized an interaction of the
twoprominentpolymorphismsCOMTVal158MetandDAT1
VNTR on individual differences in NEM as represented by
the subscales Sadness, Anger, and Fear of the ANPS. This hy-
pothesiswasconﬁrmedbyasigniﬁcantinteractionofCOMT
MetandDAT110Rleadingtolowestscoresonthepersonality
dimensionSadnessincarriersoftheVal/Valand9R/9Rgeno-
type conﬁguration. The interaction on the dimension Fear
was not signiﬁcant but on a descriptive level a trend toward
lower Fear levels of Val/Val and 9R/9R carriers was observed.
Previous studies supporting the “Yin and Yang principle
of COMT Val158Met” showed that the Val/Val genotype,
characterized by high enzyme activity leading to efﬁcient
dopamineclearancefromthesynapticcleft(Chenetal.2004),
is associated with PEM (e.g., Bressan et al. 2002) whereas the
Met allele is related to NEM (e.g., Drevets et al. 2001) and
lower enzyme activity, resulting in elevated DA levels in the
synaptic cleft. Also in the present study the observed sig-
niﬁcant main effect of the Met/Met genotype on Sadness
supports the association of the Met allele with NEM. The
Table 2. ANCOVA results of COMT Met and DAT1 10R on all dimensions of the ANPS.
Personality Dimension Interaction of COMT
of the ANPS COMT Met η2 DAT1 10R η2 Met and DAT1 10R η2
Sadness F(1,1018) = 7.55, P = 0.006 0.007 F (1,1018) = 2.97, P = 0.085 0.003 F (1,1018) = 11.11, P < 0.001 0.011
Fear F (1,1018) = 2.72, P = 0.10 0.003 F (1,1018) = 1,60, P = 0.21 0.002 F (1,1018) = 3.56, P = 0.06 0.003
Anger F (1,1019) = 4.19, P = 0.04 0.004 F (1,1019) = 1.04, P = 0.31 0.001 F (1,1019) = 1.91, P = 0.17 0.002
Seek F (1,1017) = 0.91, P = 0.34 0.001 F (1,1017) = 0.00, P = 0.97 0.000 F (1,1017) = 0.08, P = 0.78 0.000
Care F (1,1017) = 0.49, P = 0.50 0.000 F (1,1017) = 0.03, P = 0.86 0.000 F (1,1017) = 0.22, P = 0.64 0.000
Play F (1,1017) = 1.26, P = 0.26 0.001 F (1,1017) = 0.32, P = 0.57 0.000 F (1,1017) = 0.66, P = 0.42 0.001
Spirituality F (1,1018) = 1.20, P = 0.27 0.001 F (1,1018) = .10, P = 0.75 0.000 F (1,1018) = 1.29, P = 0.26 0.001
Degrees of freedom vary in the table, because not for all participants all questionnaire data of the ANPS subscales were available. Age was included
as covariate. η2 = partial eta squared.
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DA availability is further modulated through the occurrence
of the individual DAT1 variant. The 9R/9R genotype cor-
responding to lower transcription rate and therefore lower
amount of DAT1 protein results in higher DA levels through
a slower reuptake of DA into the presynapse (VanNess et al.
2005). However, it has to be mentioned that a recent meta-
analysisbyCostaetal.(Costaetal.2011)didnotcorroborate
a signiﬁcant association between the DAT1 VNTR and DAT1
availabilityinthestriatum.Despitetheheterogeneitybetween
studiesandtheunknownmechanismhowthepolymorphism
inﬂuencesDAT1expressionaffectingcognitionandemotion-
ality, the investigated genetic variants impact the personality
dimension Sadness in the investigated sample. Interestingly,
dependent on the rare 9R/9R genotype (10R-carriers), the
Val/Val genotype (Met-carriers) inﬂuences personality to-
ward less NEM. By contrast, the presence of at least one 10R
allele seems to suppress the beneﬁcial effect of the Val-allele
on NEM. In order to illustrate this effect in terms of the ex-
plained variance of the Sadness scores, it is of interest that
the main effect of the COMT SNP alone explains 0.7% of
the variance. For the DAT1, no signiﬁcant main effect was
observed but at least a trend. Both effects like hypothesized,
r e d u c e dS a d n e s si nM e t - c a r r i e r sa sw e l la si n1 0 R - c a r r i e r s .
Aspostulated,theaccumulationofbothresiliencefactorsfor
depression results in lowest Sadness scores and was visible
in an interaction effect of both polymorphisms increasing
the explained variance to 1.1%. This led us to the suggestion
that only the combination of the previously independent
with PEM-associatedalleles(Met-/10R-)resultsin decreased
NEM.
From a theoretical point of view, the genotype conﬁgura-
tion 9R/9R (10R-) and Val/Val (Met-) that is related to the
lowest Sadness scores, results in balanced DA levels due to
lower reuptake (more DA in the synaptic cleft) in combina-
tion with faster degradation of DA (leading to an adaptation
to the DAT1 10R-induced increase in synaptic DA levels). Of
course, it is in general problematic to conclude on DA levels
by taking into account only two DA polymorphisms even if
COMTandDAT1havegreatimpactonDAlevelsduetotheir
function in DA clearance. However, a balanced DA level as
inferred from the DA transporter density and DA catabolism
cannot be an explanation for the present results. The geno-
typeconﬁgurationMet+/10R+(lowDAcatabolismandhigh
DA reuptake) that is related to high Sadness scores would
theoretically result in balanced DA levels, too. This prob-
lem can be solved if we take the distribution of the proteins
withinthedifferentbrainregionsintoconsideration.DAT1is
mostabundantlyexpressedinthestriatumandmidbrainand
COMT in the prefrontal cortex (PFC), where DAT1 is only
marginallypresent(Sesacketal.1998;Lewisetal.2001).This
raisesthequestionifadirectinterplayofbothproteinsinthe
regulation of DA neurotransmission with a strong dampen-
ing effect on NEM is dependent on a balanced DA level with
low DA levels in the PFC (Met-) and high DA levels in the
striatum (10R-). This idea is corroborated by neuroimaging
studies demonstrating the importance of DA gene variations
in regulating brain circuitry involved in processing negative
emotionalstimuli(Prataetal.2009).Severallinesofevidence
indicate that both cortical and subcortical regions are acti-
vated during the presentation of emotional stimuli (Zubieta
et al. 2003) and are associated with Sadness and depression
(Haber and Brucker 2009). A recent fMRI-study by Prata et
al. (Prata et al. 2009) demonstrated signiﬁcant epistasis be-
tween DAT1 and COMT genes on cortical activation during
task-tapping executive functions in relation to schizophre-
nia, whereas the epistatic effect of DAT1 and COMT varied
in different brain areas. For this reason they speculated that
theirﬁndingspossiblyreﬂectexpressionandactivitylevelsof
the two proteins in different brain areas.
The present association study of COMT and DAT1 ge-
netic variants on Sadness explains 1.1% of variance. To gain
deeper insight into the contribution of DA genes on NEM,
further work will focus on additional polymorphisms within
these genes or others contributing to variability in DA func-
tion. A potential candidate is the DA catabolizing enzyme
Monoamine Oxidase B (MAOB) that has also been associ-
ated with NEM before (Dlugos et al. 2009). Despite the high
number of participants in this study, three-way interaction
analyses of variance were not possible because they require
an even larger sample size.
However, personality traits appear to be shaped by many
genetic variants each making a small contribution. The issue
of the relationship of genetic effects on personality variables
to clinical conditions is well established for personality traits
suchasneuroticism(beingshy,moody,anxious,andsad)rep-
resenting a vulnerability factor for depression (Kendler and
Myers 2010). Therefore, it is likely that this is also true for
the Sadness dimension of the ANPS. Moreover, the question
arises whether the continuum model for Sadness is appli-
cable to a clinical relevant sample of depressed patients. In
that case, carriers of the Val/Val and 9R/9R genotype conﬁg-
uration should show lower severity of depression in analogy
to lower expression of Sadness in healthy subjects. We sug-
gest that genotype conﬁgurations related to PEM are protec-
tive against NEM and therefore constitute a resilience factor
against depression. Additionally, the postulated distribution
of COMT and DAT1 variants resulting in balanced DA levels
could be analyzed by fMRI studies in healthy and depressed
subjects. The detection of functional and structural connec-
tivity between the PFC and striatal areas dependent on the
proposedgenotypeconﬁgurationswouldfurthersupportour
ﬁndings. Differences between depressed patients and healthy
controls reﬂecting alterations in DA function will shed light
on the contribution and impact of COMT and DAT1 in-
teraction in regional brain activation and implications for
depression.
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Inconclusion,wefoundasigniﬁcantinteractionofCOMT
× DAT1 on human personality. Thereby, the genotype
constellationCOMTVal/ValandDAT19R/9Rshowedlowest
Sadness levels and therefore might consequently contribute
toindividualdifferences inriskand resiliencefordepression.
Nevertheless, further research using molecular genetics and
genetic imaging techniques will give insights into the precise
neuralmechanismsunderlyingtheinteractionofCOMTand
DAT1.
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